The Spectrum of Kidney Disorders in Children Infected with COVID-19: A Retrospective Cohort Study
Related Experiment Video
Updated: Aug 5, 2026

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis
Published on: April 25, 2025
Eric Emmanuel T Aragon1, Ena Lauren F Farillas1, Katrina Anne T Cordova1
1Division of Pediatric Nephrology, Department of Pediatrics, Philippine General Hospital, University of the Philippines Manila.
Insights
Kidney problems are common in children with COVID-19, especially severe cases. Acute kidney injury (AKI) in these children is linked to higher mortality, highlighting the need for early detection and management.
Area of Science:
- Pediatric Nephrology
- Infectious Diseases
- Public Health
Background:
- The COVID-19 pandemic has affected multiple organ systems, including kidneys, in children.
- Limited data exists on pediatric kidney involvement in COVID-19, particularly in resource-limited settings.
- This study investigates kidney disease spectrum in Filipino children with COVID-19.
Purpose of the Study:
- To characterize kidney dysfunction incidence and types in pediatric COVID-19 patients.
- To identify risk factors associated with kidney dysfunction.
- To evaluate patient outcomes, including renal replacement therapy and mortality.
Main Methods:
- Retrospective cohort study of pediatric COVID-19 patients (RT-PCR confirmed) at Philippine General Hospital (March 2020-April 2023).
- Exclusion of patients with pre-existing kidney disease.
- Data collection on demographics, clinical status, comorbidities, and labs; kidney dysfunction defined as AKI, proteinuria, hematuria, or glucosuria.
- Logistic regression analysis for associations between kidney dysfunction, COVID-19 severity, and outcomes.
Main Results:
- 47.78% of 316 pediatric COVID-19 patients exhibited kidney involvement.
- Common manifestations included hematuria (28.48%), proteinuria (26.27%), and acute kidney injury (AKI) (14.60%).
- Severe/critical COVID-19 correlated with kidney dysfunction; AKI linked to hypertension, fever, and severe disease. Mortality was 12.03%.
Conclusions:
- Kidney dysfunction is prevalent in pediatric COVID-19, especially with severe disease.
- Acute kidney injury (AKI) significantly increases the risk of adverse outcomes and mortality.
- Prompt identification and management of renal complications are crucial for improving pediatric COVID-19 patient prognosis.
Background:
The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has impacted various organ systems, including the kidneys, in adults and children. While acute kidney injury (AKI) is well-documented in adults with COVID-19, there is limited data on kidney involvement in pediatric patients, especially in resource-limited settings like the Philippines. This study explores the spectrum of kidney diseases in children infected with COVID-19.
Objective:
The study aims to characterize the incidence and types of kidney dysfunction in pediatric COVID-19 patients, identify associated risk factors, and evaluate patient outcomes, including the need for renal replacement therapy (RRT) and mortality rates.
Methods:
This retrospective cohort study analyzed pediatric patients diagnosed with SARS-CoV-2 infection via RT-PCR, admitted to the Philippine General Hospital from March 2020 to April 2023. Patients with prior kidney disease were excluded. Data on demographic characteristics, clinical status, comorbidities, and laboratory findings were collected. Kidney dysfunction was defined as AKI, proteinuria, hematuria, or glucosuria. Associations between kidney dysfunction, COVID-19 severity, and patient outcomes were analyzed using logistic regression.
Results:
Of the 316 pediatric COVID-19 patients included, 47.78% (151) had kidney involvement, most commonly hematuria (28.48%), proteinuria (26.27%), and AKI (14.60%). Severe and critical COVID-19 were significantly associated with kidney dysfunction, while comorbidities such as oncologic/hematologic conditions decreased the odds of proteinuria and glucosuria. AKI was associated with hypertension, fever, and severe COVID-19. Mortality was 12.03%, with AKI and critical COVID-19 being significant risk factors.
Conclusion:
Kidney dysfunction is common in pediatric COVID-19 cases, particularly in severe disease. AKI was strongly associated with worse outcomes, including mortality. Early detection and management of kidney involvement are essential to improving prognosis in pediatric COVID-19 patients.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Kidney Transplant I: Introduction
